Showing results (81-90 of 216) with videos related to

Sort By:
Pageof 22
Clinical Nutrition ESPEN|February 21, 2018
Effects of goal-directed fluid therapy on enhanced postoperative recovery: An interventional comparative observational study with a historical control group on oesophagectomy combined with ERAS programHideki Taniguchi, Toshio Sasaki, Hisae Fujita, et al.
Oncology Letters|May 5, 2018
Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1Yoshihiro Suzuki, Takashi Oshima, Kazue Yoshihara, et al.
Asian Journal of Surgery|August 23, 2016
Effectiveness of alendronate for bone disorder after gastrectomy for gastric cancerYosuke Atsumi, Yasushi Rino, Tsutomu Sato, et al.
The American Journal of Surgical Pathology|October 31, 2014
A methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective, randomized, controlled studyToru Aoyama, Hirohito Fujikawa, Haruhiko Cho, et al.
Surgery Today|March 21, 2013
Human epidermal growth factor receptor 2 (Her-2) and S-1 adjuvant chemotherapy in stage 2/3 gastric cancer patients who underwent D2 gastrectomyToru Aoyama, Takaki Yoshikawa, Yohei Miyagi, et al.
Oncology Letters|July 15, 2022
Effects of perioperative eicosapentaenoic acid-enriched oral nutritional supplement on the long-term oncological outcomes after total gastrectomy for gastric cancerToru Aoyama, Takaki Yoshikawa, Satoshi Ida, et al.
Annals of Surgical Oncology|February 25, 2015
Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal TumorsToshirou Nishida, Tomoko Matsushima, Masahiko Tsujimoto, et al.
International Surgery|August 27, 2013
Laparoscopy-assisted distal gastrectomy for an early gastric cancer patient with situs inversus totalisHirohito Fujikawa, Takaki Yoshikawa, Toru Aoyama, et al.
Japanese Journal of Clinical Oncology|November 22, 2011
A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized phase II trial (COMPASS-D trial)Takaki Yoshikawa, Masataka Taguri, Shinichi Sakuramoto, et al.
BMC Surgery|July 9, 2014
Feasibility of enhanced recovery after surgery in gastric surgery: a retrospective studyTakanobu Yamada, Tsutomu Hayashi, Toru Aoyama, et al.
Pageof 22